ReIMAGINE: a prostate cancer research consortium with added value through its patient and public involvement and engagement

BACKGROUND: ReIMAGINE aims to improve the current prostate specific antigen (PSA)/biopsy risk stratification for prostate cancer (PCa) and develop a new image-based method (with biomarkers) for diagnosing high/low risk PCa in men. ReIMAGINE’s varied patient and public involvement (PPI) and engagemen...

Descripción completa

Detalles Bibliográficos
Autores principales: Green, S., Tuck, S., Long, J., Green, T., Green, A., Ellis, P., Haire, A., Moss, C., Cahill, F., McCartan, N., Brown, L., Santaolalla, A., Marsden, T., Justo, M. Rodriquez, Hadley, J., Punwani, S., Attard, G., Ahmed, H., Moore, C. M., Emberton, M., Van Hemelrijck, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596340/
https://www.ncbi.nlm.nih.gov/pubmed/34789334
http://dx.doi.org/10.1186/s40900-021-00322-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596340/
https://www.ncbi.nlm.nih.gov/pubmed/34789334
http://dx.doi.org/10.1186/s40900-021-00322-w

Ejemplares similares